Product
SRP-5051
1 clinical trial
2 indications
Indication
Muscular DystrophyIndication
DuchenneClinical trial
An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051Status: Terminated, Estimated PCD: 2021-08-25